Marketing-authorisation holder · United States
Hq Spclt Pharma
13 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CALCIUM GLUCONATE IN SODIUM CHLORIDE1gm/100ml (10mg/ml) | 1gm/50ml (20mg/ml) | 2gm/100ml (20mg/ml) · Solution | Calcium gluconate | United States | Marketed | 2017 |
| CISPLATIN10mg/vial | 1mg/ml | 50mg/vial · Injectable | Cisplatin | United States | Marketed | 1978 |
| DEXMEDETOMIDINE HYDROCHLORIDE1mg base/10ml (eq 100mcg base/ml) | 200mcg base/50ml (eq 4mcg base/ml) | 400mcg base/100ml (eq 4mcg base/ml) | 400mcg base/4ml (eq 100mcg base/ml) · Solution | Dexmedetomidine | United States | Marketed | 2015 |
| DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE100mg/100ml (1mg/ml) | 250mg/250ml (1mg/ml) · Solution | Diltiazem | United States | Marketed | 2025 |
| ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER2gm/100ml (20mg/ml) · Solution | Esmolol | United States | Marketed | 2016 |
| ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER2.5gm/250ml (10mg/ml) · Solution | Esmolol | United States | Marketed | 2016 |
| IMIPENEM AND CILASTATIN250mg base/vial; 250mg/vial | 500mg base/vial; 500mg/vial · Powder | Cilastatin, Imipenem | United States | Marketed | 2011 |
| MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER1gm/100ml | 2gm/100ml · Injectable | Magnesium sulfate | United States | Marketed | 1995 |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER20gm/500ml (40mg/ml) | 2gm/50ml (40mg/ml) | 40gm/1000ml (40mg/ml) | 4gm/100ml (40mg/ml) | 4gm/50ml (80mg/ml) · Injectable | Magnesium sulfate | United States | Marketed | 1994 |
| MEROPENEM2gm/vial · Powder | Meropenem | United States | Marketed | 2023 |
| PLATINOL10mg/vial · Injectable | Cisplatin | United States | Not marketed | 1978 |
| PLATINOL-AQ0.5mg/ml · Injectable | Cisplatin | United States | Not marketed | 1978 |
| TAXOL6MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Paclitaxel | United States | Not marketed | 1992 |